SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
木南大宝
Lv5
1
1430 积分
2024-01-31 加入
最近求助
最近应助
互助留言
Assessment of the breakthrough-therapy-designated drugs granted in China: A pooled analysis 2020–2022
2个月前
已完结
Efficacy, Safety, and Regulatory Approval of Food and Drug Administration–Designated Breakthrough and Nonbreakthrough Cancer Medicines
2个月前
已完结
Innovative drug availability in China
2个月前
已完结
Queries Raised During Oncology Business Pipeline Meetings at the European Medicines Agency: A 5‐Year Retrospective Analysis
2个月前
已完结
Analysis of Patent and Regulatory Exclusivity for Novel Agents in China and the United States: A Cohort Study of Drugs Approved Between 2018 and 2021
2个月前
已完结
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis
3个月前
已完结
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis
3个月前
已完结
High‐content analysis boosts identification of the initial cause of triptolide‐induced hepatotoxicity
6个月前
已完结
Triptolide and atorvastatin synergistically promote hepatotoxicity in cultured hepatocytes and female Sprague-Dawley rats by inhibiting pregnane X receptor-mediated transcriptional activation of CYP3A4
6个月前
已完结
The changes of gut microbiota and metabolites in different drug-induced liver injuries
6个月前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论